Sesamin
Based on 12 publication(s) in Google Scholar
Sesamin, abundant lignan found in sesame oil, is a potent and selective delta 5 desaturase inhibitor in polyunsaturated fatty acid biosynthesis. Sesamin exerts effective neuroprotection against cerbral ischemia.
For research use only. We do not sell to patients.
- Purity: 99.85%
- CAS No.: 607-80-7
- Formula: C20H18O6
- Molecular Weight:354.35
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) Sesamin
More- Phytomedicine. 2026 Jul:156:158182. [Abstract]
- Phytomedicine. 2025 May:140:156484. [Abstract]
- Int J Biol Macromol. 2025 Mar 25:142184. [Abstract]
- Chin Med. 2025 Aug 19;20(1):127. [Abstract]
- Pestic Biochem Physiol. 2026 Jan;216(Pt 1):106728. [Abstract]
- Cell Signal. 2023 Jun:106:110658. [Abstract]
- Front Biosci (Landmark Ed). 2025 Apr 25;30(4):26038. [Abstract]
- J Funct Foods. 2026 Feb 20.
- J Orthop Surg Res. 2023 Jul 31;18(1):552. [Abstract]
- J Cosmet Dermatol. 2024 Jan;23(1):316-325. [Abstract]
- Chem Biol Drug Des. 2022 Jan;99(1):118-125. [Abstract]
- Neuropsychiatr Dis Treat. 2024 Mar 7:20:523-533. [Abstract]
-
Apoptosis Analysis
-
Flow Cytometry
-
Cell Proliferation/Viability Assay
-
WB
-
In Vivo Efficacy Study
Biological Activity
delta 5 desaturase[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Daoy | ED50 |
>20 μg/mL
Compound: 14
|
Cytotoxicity against human DaOY cells after 3 days by MTT assay
Cytotoxicity against human DaOY cells after 3 days by MTT assay
|
[PMID: 21115251] |
| HeLa | ED50 |
>20 μg/mL
Compound: 14
|
Cytotoxicity against human HeLa cells after 3 days by MTT assay
Cytotoxicity against human HeLa cells after 3 days by MTT assay
|
[PMID: 21115251] |
| HEp-2 | ED50 |
>20 μg/mL
Compound: 14
|
Cytotoxicity against human Hep2 cells after 3 days by MTT assay
Cytotoxicity against human Hep2 cells after 3 days by MTT assay
|
[PMID: 21115251] |
| HepG2 | EC50 |
>60 μM
Compound: 4
|
Transactivation of PPAR expressed in HepG2 cells after 20 hrs by luminescence assay
Transactivation of PPAR expressed in HepG2 cells after 20 hrs by luminescence assay
|
[PMID: 22381047] |
| HepG2 | IC50 |
229 μM
Compound: Sesamin
|
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 31784199] |
| HepG2 | IC50 |
9.4 μM
Compound: 4
|
Inhibition of TNFalpha-induced NFkappaB transcriptional activity in human HepG2 cells pretreated for 1 hr before TNFalpha challenge by luciferase reporter gene analysis
Inhibition of TNFalpha-induced NFkappaB transcriptional activity in human HepG2 cells pretreated for 1 hr before TNFalpha challenge by luciferase reporter gene analysis
|
[PMID: 22381047] |
| KB | ED50 |
>100 μg/mL
Compound: 1
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 521819] |
| MCF7 | ED50 |
>20 μg/mL
Compound: 14
|
Cytotoxicity against human MCF7 cells after 3 days by MTT assay
Cytotoxicity against human MCF7 cells after 3 days by MTT assay
|
[PMID: 21115251] |
| Neutrophil | IC50 |
1.38 μg/mL
Compound: (+)-Episesamin
|
Antiinflammatory activity against human neutrophils assessed as inhibition of fMLP/CB-induced elastase release
Antiinflammatory activity against human neutrophils assessed as inhibition of fMLP/CB-induced elastase release
|
[PMID: 19128011] |
| Neutrophil | IC50 |
4.3 μg/mL
Compound: (+)-Episesamin
|
Antiinflammatory activity against human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation
Antiinflammatory activity against human neutrophils assessed as inhibition of fMLP/CB-induced superoxide anion generation
|
[PMID: 19128011] |
| Neutrophil | IC50 |
90.23 μM
Compound: 7, (-)-sesamin
|
Inhibition of fMLP-induced superoxide production in human neutrophils
Inhibition of fMLP-induced superoxide production in human neutrophils
|
[PMID: 17559265] |
| SH-SY5Y | IC50 |
229 μM
Compound: Sesamin
|
Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay
Cytotoxicity against human SH-SY5Y cells after 72 hrs by MTT assay
|
[PMID: 31784199] |
Pretreated with sesamin, Excess generation of nitric oxide in lipopolysaccharide-stimulated rat primary microglia cells was significantly attenuated[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 607-80-7
-
Appearance Solid
-
Molecular Weight 354.35
-
Formula C20H18O6
-
Color White to off-white
-
SMILES
[H][C@@]12[C@@H](C3=CC=C(OCO4)C4=C3)OC[C@]1([H])[C@@H](C5=CC=C(OCO6)C6=C5)OC2
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (12)
-
Journal Impact Factor
-
Most Recent
-
Phytomedicine
Sesamin ameliorates high-fat diet-induced inflammation and metabolic dysfunction in pregnant uterine smooth muscle via cGAS-STING inhibition. [Abstract]2026 Jul:156:158182. PMID: 42025545 -
Phytomedicine
Fangchinoline suppresses nasopharyngeal carcinoma progression by inhibiting SQLE to regulate the PI3K/AKT pathway dysregulation. [Abstract]2025 May:140:156484. PMID: 40090046 -
Int J Biol Macromol
Natural angiotensin II type 1 receptor inhibitors: Virtual screening and in vitro evaluation of beta-1,2,3,4,6-penta-O-galloyl-d-glucopyranose, icarrin, and sesamin for osteoarthritis therapy. [Abstract]2025 Mar 25:142184. PMID: 40147655 -
Chin Med
Identification of anti-fibrotic compounds from Piper longum L via hollow fiber cell fishing and high-performance liquid chromatography with in vivo and in vitro validation. [Abstract]2025 Aug 19;20(1):127. PMID: 40830877 -
Pestic Biochem Physiol
Sesamin exerts protective effects against diquat-induced acute kidney injury by inhibiting oxidative stress, apoptosis and autophagy: A key role for the SIRT5/FOXO3a signaling pathway. [Abstract]2026 Jan;216(Pt 1):106728. PMID: 41326063 -
Cell Signal
Expression and functional activity of myosin II in hyperplastic prostates of varying volumes. [Abstract]2023 Jun:106:110658. PMID: 36935086 -
Front Biosci (Landmark Ed)
Sesamin Exerts Anti-Tumor Activity in Nasopharyngeal Carcinoma Through Inducing Autophagy and Reactive Oxygen Species Production. [Abstract]2025 Apr 25;30(4):26038. PMID: 40302321 -
-
J Orthop Surg Res
The mechanism by which Naru 3 pill protects against intervertebral disc cartilage endplate degeneration based on network pharmacology and experimental verification. [Abstract]2023 Jul 31;18(1):552. PMID: 37525208
Sesamin purchased from MedChemExpress. Usage Cited in: J Orthop Surg Res. 2023 Jul 31;18(1):552. [Abstract]
Sesamin (1, 4, 7 μM) treatment delayed LPS-induced apoptosis in ATDC5 cells.
Sesamin purchased from MedChemExpress. Usage Cited in: J Orthop Surg Res. 2023 Jul 31;18(1):552. [Abstract]
Sesamin (1, 4, 7 μM) treatment promoted LPS-induced proliferation in ATDC5 cells and decreased the rate of EdU-positive cells by flow cytometry.
-
J Cosmet Dermatol
Sesamin attenuates UVA-induced keratinocyte injury via inhibiting ASK-1-JNK/p38 MAPK pathways. [Abstract]2024 Jan;23(1):316-325. PMID: 37545137 -
Chem Biol Drug Des
Sesamin exerts anti-tumor activity in esophageal squamous cell carcinoma via inhibition of TRIM44 and NF-κB signaling. [Abstract]2022 Jan;99(1):118-125. PMID: 34411455
Sesamin purchased from MedChemExpress. Usage Cited in: Chem Biol Drug Des. 2022 Jan;99(1):118-125. [Abstract]
Four ESCC cell lines were incubated with indicated concentrations of Sesamin overnight, and subjected to CCK-8 assay.
Sesamin purchased from MedChemExpress. Usage Cited in: Chem Biol Drug Des. 2022 Jan;99(1):118-125. [Abstract]
ECA109 and KYSE150 cells were incubated with Sesamin (0, 10, 20, 40 μM) overnight, and the protein levels of TRIM44 and TLR4 were determined by Western blot assay.
Sesamin purchased from MedChemExpress. Usage Cited in: Chem Biol Drug Des. 2022 Jan;99(1):118-125. [Abstract]
Tumor volumes were significantly decreased in Sesamin (100, 150 mg/kg, p.o.) treated groups.
-
Neuropsychiatr Dis Treat
4-Hydroxysesamin, a Modified Natural Compound, Attenuates Neuronal Apoptosis After Ischemic Stroke via Inhibiting MAPK Pathway. [Abstract]2024 Mar 7:20:523-533. PMID: 38469210
Solvent & Solubility
DMSO : 100 mg/mL (282.21 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (7.06 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (7.06 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (275 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
[1]. Cheng FC, et al. Neuroprotective effects of sesamin and sesamolin on gerbil brain in cerebral ischemia. Int J Biomed Sci. 2006 Sep;2(3):284-8. [Content Brief]
[2]. Shimizu S, et al. Sesamin is a potent and specific inhibitor of delta 5 desaturase in polyunsaturated fatty acidbiosynthesis. Lipids. 1991 Jul;26(7):512-6. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.8221 mL | 14.1103 mL | 28.2207 mL | 70.5517 mL |
| 5 mM | 0.5644 mL | 2.8221 mL | 5.6441 mL | 14.1103 mL | |
| 10 mM | 0.2822 mL | 1.4110 mL | 2.8221 mL | 7.0552 mL | |
| 15 mM | 0.1881 mL | 0.9407 mL | 1.8814 mL | 4.7034 mL | |
| 20 mM | 0.1411 mL | 0.7055 mL | 1.4110 mL | 3.5276 mL | |
| 25 mM | 0.1129 mL | 0.5644 mL | 1.1288 mL | 2.8221 mL | |
| 30 mM | 0.0941 mL | 0.4703 mL | 0.9407 mL | 2.3517 mL | |
| 40 mM | 0.0706 mL | 0.3528 mL | 0.7055 mL | 1.7638 mL | |
| 50 mM | 0.0564 mL | 0.2822 mL | 0.5644 mL | 1.4110 mL | |
| 60 mM | 0.0470 mL | 0.2352 mL | 0.4703 mL | 1.1759 mL | |
| 80 mM | 0.0353 mL | 0.1764 mL | 0.3528 mL | 0.8819 mL | |
| 100 mM | 0.0282 mL | 0.1411 mL | 0.2822 mL | 0.7055 mL |